The DR5-DAPT-SLNs enhanced cellular uptake and cytotoxicity compared to non-targeted SLNs and showed greater tumor regression in vivo compared to DAPT-SLNs and DAPT alone [62]. This evidence concerns the gene TNFRSF10B and neoplasm.